Real world treatment patterns for recurrent and metastatic head and neck cancer in the post-KEYNOTE 048 era

Real world treatment patterns for recurrent and metastatic head and neck cancer in the post-KEYNOTE 048 era

BackgroundWhile KEYNOTE-048 established anti-PD1 with or without chemotherapy as first-line treatment for recurrent and metastatic head and neck squamous cell carcinoma (HNSCC) with combined positive score (CPS) ≥ 1, treatment choice remains ambiguous given additional toxicity of combination treatme...

Full description

Saved in:
Bibliographic Details
Main Authors: Daniel Y. Lee, Alexander Pan, Maxim Yaskolko, Michael Chiorazzi, Aarti Bhatia, Barbara Burtness, Jeffrey J. Ishizuka
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Oncology
Subjects:
KEYNOTE-048
head and neck cancer
immunotherapy
pembrolizumab
cetuximab
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1577509/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2025.1577509/full

Similar Items